Deep Dive // Innovating Animal Health: The Future of Vaccine R&D
- What is the single biggest barrier to accelerating animal vaccine development today—and how can we overcome it?
- Which emerging platforms (e.g., mRNA, recombinant vectors, yeast) hold the most promise for transformative vaccine innovation?
- What role do public–private partnerships play in speeding up vaccine development and ensuring cost-effective, scalable production for modern livestock systems?
- What actions can regulators and industry take to align globally and invest in infrastructure that enables faster, more responsive vaccine development?